Moreover, the radiotherapy resistance induced by PRMT3 overexpression was reversed upon IDO1 knockdown, indicating that the radiotherapy-sensitizing effect of PRMT3 in NSCLC cells is dependent on IDO1 (Fig. 3I and J; Supplementary Fig. S7A and S7B). Here, IDO1 is linked to non-small cell lung carcinoma.